Related references
Note: Only part of the references are listed.Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates
Siaw M. Chai et al.
HISTOPATHOLOGY (2018)
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors
Amit Tirosh et al.
GASTROENTEROLOGY (2018)
Comparison of the Impact of Ga-68-DOTATATE and F-18-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
Emmanouil Panagiotidis et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements
Amit Tirosh et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA
Murat Fani Bozkurt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors
Sebastian Richards-Taylor et al.
PANCREAS (2017)
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
David L. H. Chan et al.
THERANOSTICS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with 68Ga-DOTATATE and 18F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting
Nikita Sampathirao et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2017)
Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors
Farshad Moradi et al.
CLINICAL NUCLEAR MEDICINE (2016)
A Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET/CT Scanners
Holly M. Thompson et al.
CLINICAL NUCLEAR MEDICINE (2016)
Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients
Camilla B. Johnbeck et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors
Ummuhan Abdulrezzak et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas
Taiwo Adesoye et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Multicenter Comparison of 18F-FDG and 68Ga-DOTA-Peptide PET/CT for Pulmonary Carcinoid
Filippo Lococo et al.
CLINICAL NUCLEAR MEDICINE (2015)
Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
Valentina Ambrosini et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
C. Kratochwil et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor
Punit Sharma et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Prognostic Stratification of Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms by 18F-FDG PET: Feasibility of a Metabolic Grading System
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuro endocrine Tumors: A Long-Term Evaluation
Haifa Bahri et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography
Walter Koch et al.
MOLECULAR IMAGING (2014)
Prognostic Value of Volume-Based Metabolic Parameters Measured by 18F-FDG PET/CT of Pancreatic Neuroendocrine Tumors
Ho Seong Kim et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
Hakan Geijer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
Davide Campana et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Functional Imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG
Irfan Kayani et al.
CANCER (2008)
Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors
Tina Binderup et al.
NEUROENDOCRINOLOGY (2008)
Share Paper
